| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |